Shroom for improvement: The latest on Arizona’s psilocybin trial (opens original article in a new tab)

The Scottsdale Research Institute is conducting a clinical trial on psilocybin mushrooms for PTSD treatment, using federally licensed mushrooms grown in their lab. The study, partially funded by Arizona, involves 24 participants and has faced regulatory challenges.

• Scottsdale Research Institute conducts a psilocybin trial for PTSD with 24 participants.
• The study uses federally licensed mushrooms grown in their lab, with funding from Arizona.
• Regulatory hurdles with DEA and FDA slowed the trial's progress.